E Fund Management (Hong Kong) Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History
E Fund Management (Hong Kong) Co., Ltd.
- $125 Million
- Q4 2024
A detailed history of E Fund Management (Hong Kong) Co., Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, E Fund Management (Hong Kong) Co., Ltd. holds 9 shares of REGN stock, worth $5,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 2
350.0%
Holding current value
$5,708
Previous $2,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,497Shares Held
85.8MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.89 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.36 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.48 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.06 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $68B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...